Cyntellect Gets $500,000 Grant to Develop Transfection Technology | GenomeWeb

Cyntellect announced this week that it has received a phase II SBIR grant worth $500,000 from the National Science Foundation to develop its laser-based transfection technology.

The technology — known as LEAP, or laser-enabling analysis and processing — involves temporarily permeabilizing cells with a laser so that a variety of molecules, including siRNAs, can be transfected. The laser is also used to destroy untransfected cells, so that researchers end up with a pure set of transfected cells.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.